Clinical Trial Update: A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treatment intensification with ABI-H0731 in chronic hepatitis B patients on nucleos(t)ide reverse transcriptase inhibitors was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ABI-H0731

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2022-10-20